Search

Your search keyword '"Vogt U"' showing total 598 results

Search Constraints

Start Over You searched for: Author "Vogt U" Remove constraint Author: "Vogt U"
598 results on '"Vogt U"'

Search Results

352. [Rare malignant tumor of the parotid gland. Myoepithelial carcinoma].

353. Sub-25-nm laboratory x-ray microscopy using a compound Fresnel zone plate.

354. High-resolution computed tomography with a compact soft x-ray microscope.

355. Theoretical development of a high-resolution differential-interference-contrast optic for x-ray microscopy.

356. Molecular targeted therapies for breast cancer treatment.

357. Simulation of partially coherent image formation in a compact soft X-ray microscope.

358. Laboratory arrangement for soft x-ray zone plate efficiency measurements.

359. Comparison of conventional and silicone hydrogel contact lenses for bullous keratoplasty.

360. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival.

361. Condenser for Koehler-like illumination in transmission x-ray microscopes at undulator sources.

362. Therapeutic use of silicone hydrogel contact lenses in children.

363. Whole genome expression analysis for biologic rational pathway modeling: application in cancer prognosis and therapy prediction.

364. Single-optical-element soft-x-ray interferometry with a laser-plasma x-ray source.

365. Mechanical properties of femoral trabecular bone in dogs.

366. Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.

367. Breast tumour growth inhibition in vitro through the combination of cyclophosphamide/metotrexate/5-fluorouracil, epirubicin/cyclophosphamide, epirubicin/paclitaxel, and epirubicin/docetaxel with the bisphosphonates ibandronate and zoledronic acid.

368. Quantitative analysis of the in situ Fourier transform infrared absorption and emission spectrum of gas-phase SiO (Deltav = 1 and 2) produced in Si-N-O fiber growth.

369. Viroid-induced RNA silencing of GFP-viroid fusion transgenes does not induce extensive spreading of methylation or transitive silencing.

370. High-throughput analysis of genome-wide receptor tyrosine kinase expression in human cancers identifies potential novel drug targets.

371. Kersley lecture: eye believe in contact lenses: contact lenses and/or refractive surgery.

372. [Impact of DNA image cytometry (ICM) parameter and established prognostic factors on disease free survival (DFS) and overall survival (OS) of node-negative breast cancer (NNBC) patients].

373. [Remission rate of mediastinal lymph nodes after multimodal therapy of lung cancer--is it a prognostic factor?].

374. A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer.

375. Cyclin A1 is highly expressed in aggressive testicular germ cell tumors.

376. C-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancer.

377. Ultrashort 1-kHz laser plasma hard x-ray source.

378. Xenobiotics in the environment: present and future strategies to obviate the problem of biological persistence.

379. Evaluation of the energetic position of the lowest excited singlet state of beta-carotene by NEXAFS and photoemission spectroscopy.

380. Binding of IRE-BP to its cognate RNA sequence: SFM studies on a universal RNA backbone for the analysis of RNA-protein interaction.

381. Hydraulic vulnerability, vessel refilling, and seasonal courses of stem water potential of Sorbus aucuparia L. and Sambucus nigra L.

383. [Clinical importance of histology, grading and ploidies in primary breast cancer].

384. Human orosomucoid polymorphism: molecular basis of the three common ORM1 alleles, ORM1*F1, ORM1*F2, and ORM1*S.

385. [Pseudo-esophagitis in antacid abuse].

386. Analysis of the inter-alpha-trypsin inhibitor polymorphism in west Africa: description of a new allele, ITI*7.

387. The polymorphism of the plasma inter-alpha-trypsin inhibitor (ITI) and its relationship to the heavy chain H1 subunit gene (ITIH1) at 3p211-212.

388. Genetic polymorphism of apolipoprotein H (beta 2-glycoprotein I) in African blacks from the Ivory Coast.

389. Inter-alpha-trypsin inhibitor polymorphism in African blacks.

390. The ITI system in South Koreans and Iranians analysed by an improved classification procedure. Distribution of alleles and description of "new" phenotypes.

391. The examination of the ITI system in disputed paternities.

392. A "new" genetic polymorphism of a human serum protein: inter-alpha-trypsin-inhibitor.

393. [On the dissemination of B-cell non-Hodgkin lymphomas at the time of diagnosis].

Catalog

Books, media, physical & digital resources